To the Editor:

Patients with emergent gynecologic hemorrhage are characterized by having acute onset and massive bleeding, such as with ectopic pregnancy rupture and bleeding, incomplete abortion, especially cesarean scar pregnancy abortion, and cervical pregnancy abortion. Excessive blood loss, hemorrhagic shock, and even life-threatening events can occur if treatment is not timely. This consensus was led by the Reproductive Health Branch of the Chinese Preventive Medicine Association, the Gynaecological Endoscopy Professional Committee of the Chinese Medical Doctor Association, and the Gynaecological Endoscopy Branch of the Beijing Medical Association.

Triage Process of Emergency Treatment {#sec0001}
=====================================

Patients with suspected cases should visit fever clinics for further investigation under the guidance of specific personnel through designated channels. For patients who are critically ill, cannot visit fever clinics, and will be in a life-threatening condition if not treated imminently, hospital consultation procedures should be initiated. Those unable to be confirmed for coronavirus disease are considered suspected individuals. We suggest that whether complicated with fever and/or respiratory symptoms or epidemiologic history, patients should be admitted immediately and transferred to isolation wards or isolation operating rooms for emergency treatment by well-protected medical staff according to emergency procedures. Patients with infection-eliminated cases should be treated according to the disposition process of emergent gynecologic hemorrhage ([Fig. 1](#fig0001){ref-type="fig"} ).Fig. 1Workflow of emergency treatment. EMS = endometriosis; COVID-19 = coronavirus disease; CRP = C-reactive protein; HCG = human chorionic gonadotropin; PCT = procalcitonin.Fig 1

Treatment Procedure {#sec0002}
===================

Conservative Treatment {#sec0003}
----------------------

Conservative treatment should be given to patients with stable vital signs, excluding abortion, residual tissue inside the uterine cavity, and genital tract space-occupying lesions, or patients whose bleeding can be controlled with medication, as assessed by doctors. Common medications [@bib0001] include hemostasis medication, hormonal medications, and uterotonic agents. The selection and dosage of medications should be considered according to the relevant diagnosis and treatment specifications and the specific conditions of patients [@bib0002]. The physician needs to determine whether the patient\'s condition can be treated in the emergency department or transferred to the ward for observation. Before hospitalization, coronavirus disease screening must be completed ([Fig. 2](#fig0002){ref-type="fig"} ) [@bib0003].Fig. 2Workflow of conservative treatment during the COVID-19 epidemic. COVID-19 = coronavirus disease; ED = emergency department.Fig 2

Surgical Treatment {#sec0004}
------------------

Surgical treatment applies to patients with excessive bleeding and unstable vital signs, including massive hemorrhage caused by pregnancy-relevant incomplete abortion, ruptured ectopic pregnancy and cesarean scar pregnancy abortion, endometrial abnormal hyperplasia/lesions in perimenopausal women, sudden hemorrhage caused by benign and malignant tumors of the genital system, and conditions evaluated by physicians requiring surgical intervention to control bleeding. Surgical treatments include emergency curettage, laparoscopic and laparotomic exploration, and vascular interventional therapy [@bib0004]. The surgical methods should be selected by a comprehensive analysis according to the specific condition of the patient. Patients requiring surgical treatment should be managed in accordance with inpatient management requirements ([Fig. 3](#fig0003){ref-type="fig"} ) [@bib0005].Fig. 3Workflow of surgical treatment during the COVID-19 epidemic. COVID-19 = coronavirus disease.Fig 3
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